Treatment of tubular damage in high-fat-diet-fed obese mice using sodium-glucose co-transporter inhibitors

A long-term high-fat diet (HFD) causes obesity and changes in renal lipid metabolism and lysosomal dysfunction in mice, causing renal damage. Sodium-glucose co-transporter inhibitors, including phlorizin, exert nephroprotective effects in patients with chronic kidney disease, but the underlying mechanism remains unclear. A HFD or standard diet was fed to adult C57BL/6J male mice, and phlorizin was administered. Lamellar body components of the proximal tubular epithelial cells (PTECs) were investigated. After phlorizin administration in HFD-fed mice, sphingomyelin and ceramide in urine and tissues were assessed and label-free quantitative proteomics was performed using kidney tissue samples. Mitochondrial elongation by fusion was effective in the PTECs of HFD-fed obese mice under phlorizin administration, and many lamellar bodies were found in the apical portion of the S2 segment of the proximal tubule. Phlorizin functioned as a diuretic, releasing lamellar bodies from the apical membrane of PTECs and clearing the obstruction in nephrons. The main component of the lamellar bodies was sphingomyelin. On the first day of phlorizin administration in HFD-fed obese mice, the diuretic effect was increased, and more sphingomyelin was excreted through urine than in vehicle-treated mice. The expressions of three peroxisomal β-oxidation proteins involved in fatty acid metabolism were downregulated after phlorizin administration in the kidneys of HFD-fed mice. Fatty acid elongation protein levels increased with phlorizin administration, indicating an increase in long-chain fatty acids. Lamellar bodies accumulated in the proximal renal tubule of the S2 segment of the HFD-fed mice, indicating that the urinary excretion of lamellar bodies has nephroprotective effects.

[1]  Zijian Wu,et al.  Dietary Supplementation of Apple Phlorizin Attenuates the Redox State Related to Gut Microbiota Homeostasis in C57BL/6J Mice Fed with a High-Fat Diet. , 2020, Journal of agricultural and food chemistry.

[2]  S. Verma,et al.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function. , 2020, Annual review of physiology.

[3]  Jian Sun,et al.  High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction , 2020, Cell Death & Disease.

[4]  Satoshi Shimo,et al.  Sodium-glucose co-transporter (SGLT) inhibitor restores lost axonal varicosities of the myenteric plexus in a mouse model of high-fat diet-induced obesity , 2020, Scientific Reports.

[5]  Kenji Tsuji,et al.  Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice , 2020, International journal of molecular sciences.

[6]  S. Saitoh,et al.  Glomerular Cellular Interactions Following Disruption of the Glomerular Basement Membrane in IgA Nephropathy: Ultrastructural Analyses by 3-Dimensional Serial Block-Face Scanning Electron Microscopy , 2020, Kidney medicine.

[7]  S. Saitoh,et al.  Podocyte penetration of the glomerular basement membrane to contact on the mesangial cell at the lesion of mesangial interposition in lupus nephritis: a three-dimensional analysis by serial block-face scanning electron microscopy , 2019, Clinical and Experimental Nephrology.

[8]  A. Durak,et al.  A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats , 2018, Cardiovascular Diabetology.

[9]  A. Ballabio,et al.  Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney , 2018, The Journal of pathology.

[10]  Tetsuhiro Tanaka,et al.  Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice. , 2018, Kidney international.

[11]  Christopher S. Hughes,et al.  Single-pot, solid-phase-enhanced sample preparation for proteomics experiments , 2018, Nature Protocols.

[12]  R. Eckel,et al.  Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[13]  H. Heerspink,et al.  Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. , 2018, Kidney international.

[14]  A. Murphy,et al.  SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice. , 2018, Atherosclerosis.

[15]  D. Koya,et al.  Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet , 2018, Journal of diabetes investigation.

[16]  M. Czech Insulin action and resistance in obesity and type 2 diabetes , 2017, Nature Medicine.

[17]  Y. Isaka,et al.  High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney. , 2017, Journal of the American Society of Nephrology : JASN.

[18]  N. Câmara,et al.  Kidney disease and obesity: epidemiology, mechanisms and treatment , 2017, Nature Reviews Nephrology.

[19]  E. Tai,et al.  Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease , 2016, Kidney international reports.

[20]  P. Greimel,et al.  Separation and analysis of mono-glucosylated lipids in brain and skin by hydrophilic interaction chromatography based on carbohydrate and lipid moiety. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  N. Kitamura,et al.  Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet-Induced Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.

[22]  P. Dorrestein,et al.  Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator , 2016, EBioMedicine.

[23]  A. Snider,et al.  Sphingolipids in High Fat Diet and Obesity-Related Diseases , 2015, Mediators of inflammation.

[24]  Katsumasa Fujita,et al.  Sphingomyelin distribution in lipid rafts of artificial monolayer membranes visualized by Raman microscopy , 2015, Proceedings of the National Academy of Sciences.

[25]  M. Coughlan,et al.  Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? , 2014, British journal of pharmacology.

[26]  D. Bates,et al.  Resolution of the three dimensional structure of components of the glomerular filtration barrier , 2014, BMC Nephrology.

[27]  G. Schmitz,et al.  Lipidomic Analysis of Serum from High Fat Diet Induced Obese Mice , 2014, International journal of molecular sciences.

[28]  A. Tojo The role of the kidney in protein metabolism: the capacity of tubular lysosomal proteolysis in nephrotic syndrome. , 2013, Kidney international.

[29]  K. Sharma,et al.  Autophagy and metabolic changes in obesity-related chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  T. Ideker,et al.  Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. , 2013, Journal of the American Society of Nephrology : JASN.

[31]  E. Lerut,et al.  Phlorizin Pretreatment Reduces Acute Renal Toxicity in a Mouse Model for Diabetic Nephropathy* , 2013, The Journal of Biological Chemistry.

[32]  Faisal T Thayyullathil,et al.  Role of ceramide in diabetes mellitus: evidence and mechanisms , 2013, Lipids in Health and Disease.

[33]  C. Argmann,et al.  Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids , 2012, Journal of Lipid Research.

[34]  Johannes E. Schindelin,et al.  TrakEM2 Software for Neural Circuit Reconstruction , 2012, PloS one.

[35]  B. Rothermel,et al.  Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics. , 2012, The international journal of biochemistry & cell biology.

[36]  C. Schnell,et al.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice , 2011, Human molecular genetics.

[37]  Gregory Kaltsas,et al.  Metabolic syndrome: definitions and controversies , 2011, BMC medicine.

[38]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[39]  E. Christensen,et al.  Functional Ultrastructure of the Proximal Tubule , 2011 .

[40]  M. Nangaku,et al.  Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  Jeremy C. Allegood,et al.  Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] , 2009, Journal of Lipid Research.

[42]  N. Lewis,et al.  Phlorizin: a review , 2005, Diabetes/metabolism research and reviews.

[43]  M. Fartasch The epidermal lamellar body: a fascinating secretory organelle. , 2004, The Journal of investigative dermatology.

[44]  T. Hammond,et al.  Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules. , 1995, European journal of cell biology.

[45]  G. Schmitz,et al.  Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. , 1991, Journal of lipid research.

[46]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.

[47]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.